1,523
Views
48
CrossRef citations to date
0
Altmetric
Original Articles

Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization

, N.M.D. & , Ph.D.

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Carolyn E. Pritchett, Heather Flynn, Yuxia Wang & James E. Polston. (2022) Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use. Substance Use & Misuse 57:13, pages 1883-1892.
Read now
Neta HaGani, Sharon Sznitman, Michael Dor, Gil Bar-Sela, Dana Oren, Lilia Margolis-Dorfman, Itay Goor-Aryeh & Manfred S Green. (2022) Attitudes Toward the Use of Medical Cannabis and the Perceived Efficacy, Side-effects and Risks: A Survey of Patients, Nurses and Physicians. Journal of Psychoactive Drugs 54:5, pages 393-402.
Read now
Brianna Costales, Sascha van Boemmel-Wegmann, Almut Winterstein & Richard Segal. (2021) Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida. Journal of Psychoactive Drugs 53:3, pages 185-194.
Read now
John Laurence Arnfinsen & Adnan Kisa. (2021) Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis. Drugs: Education, Prevention and Policy 28:2, pages 165-171.
Read now
Jacob T. Borodovsky & Alan J. Budney. (2018) Cannabis regulatory science: risk–benefit considerations for mental disorders. International Review of Psychiatry 30:3, pages 183-202.
Read now
Gordon D Ko, Sara L Bober, Sean Mindra & Jason M Moreau. (2016) Medical cannabis – the Canadian perspective. Journal of Pain Research 9, pages 735-744.
Read now

Articles from other publishers (42)

José F. Ramírez-Méndez, Pedro Wong-Salgado, Peter Gámez, Pedro Solis & Jeel Moya-Salazar. (2024) Patients' knowledge about the uses, risks, and beliefs surrounding the regulation and safety of Cannabis sativa L. in Peru. Heliyon 10:7, pages e27068.
Crossref
Lucie Malikova, Matej Malik, Jan Pavlik, Milos Ulman, Eva Pechouckova, Milos Skrivan, Ladislav Kokoska & Pavel Tlustos. (2024) Anti-staphylococcal activity of soilless cultivated cannabis across the whole vegetation cycle under various nutritional treatments in relation to cannabinoid content. Scientific Reports 14:1.
Crossref
Kevin F. Boehnke, Christopher L. WuDaniel J. Clauw. (2023) Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment. Anesthesia & Analgesia 138:1, pages 5-15.
Crossref
J. Ryan Scott, David A. Williams, Steven E. Harte, Richard E. Harris, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw & Kevin F. Boehnke. (2024) Relationship Between Nociplastic Pain Involvement and Medication Use, Symptom Relief, and Adverse Effects Among People Using Medical Cannabis for Chronic Pain. The Clinical Journal of Pain 40:1, pages 1-9.
Crossref
Katrina Gething, Daniel Erku & Paul Scuffham. (2023) Stakeholders' Decisions and Preferences for the Provision and Use of Medicinal Cannabis: A Scoping Review. Cannabis and Cannabinoid Research 8:6, pages 986-998.
Crossref
Eric L. Sevigny, Jared Greathouse & Danye N. Medhin. (2023) Health, safety, and socioeconomic impacts of cannabis liberalization laws: An evidence and gap map. Campbell Systematic Reviews 19:4.
Crossref
Matěj Malík, Lukáš Praus & Pavel Tlustoš. (2023) Comparison of recirculation and drain-to-waste hydroponic systems in relation to medical cannabis (Cannabis sativa L.) plants. Industrial Crops and Products 202, pages 117059.
Crossref
Andrew Davis. (2023) Canadian Medical Cannabis Use after Legalization. Canadian Public Policy 49:3, pages 293-305.
Crossref
Elise Lorenzo, Carina McClean & Jason A. Ford. (2023) Young Adult Medical Cannabis Patients in Florida: Gender Differences in Characteristics of use, Experiences at Dispensaries, and Association With Health-Related Problems. Journal of Drug Issues.
Crossref
Elizabeth N. R. Schjelderup, Caroline A. MacCallum, Lindsay A. Lo, Jessie Dhillon, April Christiansen, Carly Pistawka, Kathryn Rintoul, William J. Panenka & Alasdair M. Barr. (2023) Exploring medical cannabis use in individuals with a traumatic brain injury. Exploration of Medicine, pages 393-408.
Crossref
Eric Fordjour, Charles F. Manful, Albert A. Sey, Rabia Javed, Thu Huong Pham, Raymond Thomas & Mumtaz Cheema. (2023) Cannabis: a multifaceted plant with endless potentials. Frontiers in Pharmacology 14.
Crossref
Martha S. Rosenthal. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids 3 14 .
Rebecca E. Olson, Alexandra Smith, Georgie Huggett, Phillip Good, Morgan Dudley & Janet Hardy. (2022) Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer. Trials 23:1.
Crossref
Rebecca L. Ashare, Erin Kelly, Emily R. Hajjar, Swechhya Pant, Salimah H. Meghani & Brooke Worster. (2022) Characterizing anxiety, pain, sleep, and quality of life among patients in a state Medical Marijuana Program. Complementary Therapies in Clinical Practice 48, pages 101612.
Crossref
Lihi Bar-Lev Schleider, Raphael Mechoulam, Inbal Sikorin, Timna Naftali & Victor Novack. (2022) Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study. Frontiers in Medicine 9.
Crossref
Debra Kimless, Matthew Caloura, Virginia Markos, Jennie Ryan, Sally Abbonizio & Sharon Janicki. (2022) An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania. Journal of Primary Care & Community Health 13, pages 215013192211297.
Crossref
Jeremy Y. Ng, Amanda Abrams, Ananya Pathak, Umair Tahir & Jane Jomy. (2022) What are the experiences of patients using cannabis for pain? A systematic review of qualitative studies. European Journal of Integrative Medicine 49, pages 102098.
Crossref
Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye & Clermont E. Dionne. (2021) Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. Journal of Cannabis Research 3:1.
Crossref
Geoffrey P. Jacobs, Taylor Golshan, Sarah Lande, Kaitlyn Nickfardjam, Yulia Roitblat, Antony Morgan, Tatum Mayo, Kadri Mametov, Liliia Nehuliaieva & Michael Shterenshis. (2021) Knowledge and attitudes of adolescents to marijuana: An international prospective study. Children and Youth Services Review 131, pages 106306.
Crossref
Matěj Malík, Jiří Velechovský & Pavel Tlustoš. (2021) The overview of existing knowledge on medical cannabis plants growing. Plant, Soil and Environment 67:8, pages 425-442.
Crossref
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2021) Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduction Journal 18:1.
Crossref
Kelly A. Sagar, M. Kathryn Dahlgren, Ashley M. Lambros, Rosemary T. Smith, Celine El-Abboud & Staci A. Gruber. (2021) An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results. Journal of the International Neuropsychological Society 27:6, pages 648-660.
Crossref
Howard Meng, M. Gabrielle Page, Prabjit Ajrawat, Amol Deshpande, Bana Samman, Mary Dominicis, Karim S. Ladha, Joseph Fiorellino, Alexander Huang, Yuvaraj Kotteeswaran, Alex McClaren-Blades, Lakshmi P. Kotra & Hance Clarke. (2021) Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patientsRésultats rapportés par les patients consommant du cannabis médical : une étude observationnelle longitudinale prospective chez des patients souffrant de douleur chronique. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 68:5, pages 633-644.
Crossref
Henry Jair Mayorga Anaya, María Paula Torres Ortiz, Daniel Hernando Flórez Valencia & Omar Fernando Gomezese Ribero. (2021) Efficacy of cannabinoids in fibromyalgia: a literature review. Colombian Journal of Anesthesiology.
Crossref
Manuela Mazza. (2021) Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series. Journal of Cannabis Research 3:1.
Crossref
Leigh Alon, Douglas Bruce, Olivia Blocker, Alida M. Bouris, Daniel H. Reirden & John A. Schneider. (2021) Perceptions of quality and safety in cannabis acquisition amongst young gay and bisexual men living with HIV/AIDS who use cannabis: Impact of legalisation and dispensaries. International Journal of Drug Policy 88, pages 103035.
Crossref
Martha S. Rosenthal & R. Nathan Pipitone. (2020) Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida. Medical Cannabis and Cannabinoids 4:1, pages 13-20.
Crossref
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw, Jenna Goesling & David A. Williams. (2019) Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain. The Journal of Pain 20:11, pages 1362-1372.
Crossref
Jesse D. Kosiba, Stephen A. Maisto & Joseph W. Ditre. (2019) Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine 233, pages 181-192.
Crossref
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, David A. Williams & Daniel J. Clauw. (2019) Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain. The Journal of Pain 20:7, pages 830-841.
Crossref
Laura Daly, Caroline E. Gibson & Jan Dewing. (2019) Caring for people with multiple sclerosis who use cannabis for symptom control. British Journal of Community Nursing 24:6, pages 257-257.
Crossref
A.-P. Trouvin & S. Perrot. (2019) Cannabis : enjeux et risques en médecine de la douleur. Douleur et Analgésie 32:2, pages 73-78.
Crossref
Gabrielle Campbell, Emily Stockings & Suzanne Nielsen. (2019) Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 135-144.
Crossref
Seema Mutti-Packer, Brianne Collyer & David C. Hodgins. (2018) Perceptions of plain packaging and health warning labels for cannabis among young adults: findings from an experimental study. BMC Public Health 18:1.
Crossref
George Habib & Suheil Artul. (2018) Medical Cannabis for the Treatment of Fibromyalgia. JCR: Journal of Clinical Rheumatology 24:5, pages 255-258.
Crossref
George Habib & Irit Avisar. (2018) The Consumption of Cannabis by Fibromyalgia Patients in Israel. Pain Research and Treatment 2018, pages 1-5.
Crossref
Gabrielle Campbell, Wayne D Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P Mattick, Fiona Blyth, Marian Shanahan, Timothy Dobbins, Michael Farrell & Louisa Degenhardt. (2018) Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. The Lancet Public Health 3:7, pages e341-e350.
Crossref
Kim Madden, Niek van der Hoek, Simrun Chona, Annie George, Tristiana Dalchand, Hassan Baldawi, George Mammen & Mohit Bhandari. (2018) Cannabinoids in the Management of Musculoskeletal Pain. JBJS Reviews 6:5, pages e7-e7.
Crossref
Des Crowley, Claire Collins, Ide Delargy, Eamon Laird & Marie Claire Van Hout. (2017) Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduction Journal 14:1.
Crossref
William D. TrouttMatthew D. DiDonato. (2017) Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents. The Journal of Alternative and Complementary Medicine 23:11, pages 879-884.
Crossref
Brian J. Piper, Monica L. Beals, Alexander T. Abess, Stephanie D. Nichols, Maurice W. Martin, Catherine M. Cobb & Rebecca M. DeKeuster. (2017) Chronic pain patients' perspectives of medical cannabis. Pain 158:7, pages 1373-1379.
Crossref
Marie Claire Van Hout, Claire Collins, Ide Delargy & Des Crowley. (2016) Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP). International Journal of Mental Health and Addiction 15:3, pages 670-683.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.